Epidemiologic observations guiding clinical application of a urinary peptidomic marker of diastolic left ventricular dysfunction

Zhen-Yu Zhang, Esther Nkuipou-Kenfack, Wen-Yi Yang, Fang-Fei Wei, Nicholas Cauwenberghs, Lutgarde Thijs, Qi-Fang Huang, Ying-Mei Feng, Joost P. Schanstra, Tatiana Kuznetsova, Jens-Uwe Voigt, Peter Verhamme, Harald Mischak, Jan A. Staessen

    Research output: Contribution to journalArticleAcademicpeer-review

    Original languageEnglish
    Pages (from-to)438-447.e4
    Number of pages10
    JournalJournal of the American Society of Hypertension
    Volume12
    Issue number6
    DOIs
    Publication statusPublished - 1 Jun 2018

    Keywords

    • Diastolic left ventricular function
    • population science
    • screening
    • urinary proteomics
    • PRESERVED EJECTION FRACTION
    • AMBULATORY BLOOD-PRESSURE
    • GENERAL-POPULATION
    • PROTEOME ANALYSIS
    • HEART-FAILURE
    • RENAL-FUNCTION
    • DISEASE
    • PREVALENCE
    • GUIDELINES
    • DISCOVERY
    • STANDARDS

    Cite this

    Zhang, Z-Y., Nkuipou-Kenfack, E., Yang, W-Y., Wei, F-F., Cauwenberghs, N., Thijs, L., Huang, Q-F., Feng, Y-M., Schanstra, J. P., Kuznetsova, T., Voigt, J-U., Verhamme, P., Mischak, H., & Staessen, J. A. (2018). Epidemiologic observations guiding clinical application of a urinary peptidomic marker of diastolic left ventricular dysfunction. Journal of the American Society of Hypertension, 12(6), 438-447.e4. https://doi.org/10.1016/j.jash.2018.03.007